Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
211 participants
OBSERVATIONAL
2021-09-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Vision Screening in High-risk Children
NCT02678468
Choroidal Change on OCTA in Eyes With High Myopia
NCT04255524
Optical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age)
NCT03399825
A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
NCT01335113
Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography
NCT04631978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Settings and Design: Prospective Cross-Sectional Study
Methods and Material: The study was conducted prospectively in the ophthalmology department of Ankara Bilkent City Hospital. Subjects were divided into three groups: 29 children who were treated with laser photocoagulation (ROP-TxGroup), 26 children who developed ROP and did not need treatment (ROP-non-TxGroup), and 25 children who did not develop ROP (Premature Group). The 27 healthy children with a history of full-term born (Control Group), who were in a similar age group for 'control eye examination', were accepted as the control group. A total of 107 patients and 211 eyes were included in the study. Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), keratometry, axial length (AL) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ROP-Tx Group
less than 37 weeks were divided into three groups: 29 children born prematurely who were treated with laser photocoagulation
axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT)
Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
ROP-non-Tx Group
26 children who developed ROP and did not need treatment
axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT)
Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
Premature Group
25 children who did not develop ROP
axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT)
Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
Control Group
27 healthy children with a history of full-term born
axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT)
Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT)
Non-cycloplegic and cycloplegic refraction, best corrected visual acuity (BCVA), axial length (AU) and anterior chamber depth (ACD), optical coherence tomography (OCT) macular and OCT subfoveal choroidal measurements were performed in all cases.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Kutay KILINÇ
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali Kutay KILINÇ
Role: STUDY_CHAIR
Ankara City Hospital Bilkent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital Bilkent
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AKU749K
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.